Telix Innovations Drug Patent Portfolio
Telix Innovations owns 1 orange book drug protected by 1 US patent Given below is the list of Telix Innovations's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11027031 | Kit for radiolabelling | 28 Jul, 2035 | Active |
Telix Innovations's Family Patents
Telix Innovations drugs have patent protection in a total of 18 countries. It's US patent count contributes only to 21.3% of its total global patent coverage. Click
below to unlock the full patent family tree.
Telix Innovations Drug List
Given below is the complete list of Telix Innovations's drugs and the patents protecting them.
1. Gozellix
Gozellix is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11027031 | Kit for radiolabelling |
28 Jul, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gozellix's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List